News
Vaccine advisers to consider MMRV vaccines, ‘thimerosal containing’ flu shots in pared-down meeting
The updated agenda for the Advisory Committee on Immunization Practices comes a week after Kennedy announced he had dismissed all 17 members of the independent panel, which provides recommendations to the Centers for Disease Control and Prevention on which vaccines people should get.
A leading infectious disease expert and one of the nation’s foremost COVID-19 researchers has voiced deep concerns about the ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
A few of the new members Health Secretary Robert F. Kennedy Jr. appointed to the federal panel have promoted misinformation about vaccines and public health.
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a ...
Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback